Evidence map›Paper›PMID 34613626›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2021

Lysine methyltransferase 2D regulates muscle fiber size and muscle cell differentiation.

Alec Wright, Arielle Hall, Tara Daly, Tatiana Fontelonga, Sarah Potter, Caitlin Schafer, Andrew Lindsley, Christina Hung, Olaf Bodamer, Emanuela Gussoni

Open access · hybridAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Lysine methyltransferase 2D regulates muscle fiber size and muscle cell differentiation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Alec WrightDivision of Genetics and Genomics, Boston Children's Hospital, Boston, Massachusetts, USA.
Arielle HallDivision of Genetics and Genomics, Boston Children's Hospital, Boston, Massachusetts, USA.
Tara DalyDivision of Genetics and Genomics, Boston Children's Hospital, Boston, Massachusetts, USA.
Tatiana FontelongaDivision of Genetics and Genomics, Boston Children's Hospital, Boston, Massachusetts, USA.
Sarah PotterDivision of Allergy and Immunology, Cincinnati Children's Hospital, Cincinnati, Ohio, USA.
Caitlin SchaferDivision of Allergy and Immunology, Cincinnati Children's Hospital, Cincinnati, Ohio, USA.
Andrew LindsleyDivision of Allergy and Immunology, Cincinnati Children's Hospital, Cincinnati, Ohio, USA.
Christina HungDivision of Genetics and Genomics, Boston Children's Hospital, Boston, Massachusetts, USA.
Olaf BodamerDivision of Genetics and Genomics, Boston Children's Hospital, Boston, Massachusetts, USA.
Emanuela GussoniDivision of Genetics and Genomics, Boston Children's Hospital, Boston, Massachusetts, USA.ORCID 0000-0002-9915-3677
Boston Children's Hospital · USCincinnati Children's Hospital Medical Center · USBroad Institute · US

Funding

Genetic Analysis and Manipulation Core (GAEC)P50HD105351 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI SCOTT Loren POMEROY, MUSTAFA SAHIN · 2021 to 2026
$9.4M
Tetraspanin CD82 in muscle satellite cells quiescence and differentiationR01AR069582 · NIAMS · BOSTON CHILDREN'S HOSPITAL · PI GUSSONI, EMANUELA · 2017 to 2022
$1.9M
NIAMS NIH HHS R01 AR069582NICHD NIH HHS P50 HD105351
6 · The paper itself

Abstract

Kabuki syndrome (KS) is a rare genetic disorder caused primarily by mutations in the histone modifier genes KMT2D and KDM6A. The genes have broad temporal and spatial expression in many organs, resulting in complex phenotypes observed in KS patients. Hypotonia is one of the clinical presentations associated with KS, yet detailed examination of skeletal muscle samples from KS patients has not been reported. We studied the consequences of loss of KMT2D function in both mouse and human muscles. In mice, heterozygous loss of Kmt2d resulted in reduced neuromuscular junction (NMJ) perimeter, decreased muscle cell differentiation in vitro and impaired myofiber regeneration in vivo. Muscle samples from KS patients of different ages showed presence of increased fibrotic tissue interspersed between myofiber fascicles, which was not seen in mouse muscles. Importantly, when Kmt2d-deficient muscle stem cells were transplanted in vivo in a physiologic non-Kabuki environment, their differentiation potential is restored to levels undistinguishable from control cells. Thus, the epigenetic changes due to loss of function of KMT2D appear reversible through a change in milieu, opening a potential therapeutic avenue.

Indexed as

Abnormalities, MultipleAdolescentAnimalsCell DifferentiationChildChild, PreschoolDisease Models, AnimalDNA-Binding ProteinsFaceFemaleHematologic DiseasesHistone-Lysine N-MethyltransferaseHumansInfantMaleMiceDNA-Binding ProteinsHistone-Lysine N-MethyltransferaseKMT2D protein, humanKmt2d protein, mouseMyeloid-Lymphoid Leukemia ProteinNeoplasm ProteinsKabuki syndromemuscle differentiationmuscle regenerationmuscle stem cellsmuscular dystrophyNMJ

Identifiers

PMID34613626
PMCPMC8500524
OpenAlexW3203468823

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.